InicioSHPMY • OTCMKTS
add
Shanghai Pharmaceuticals Holdings ADR
Cierre anterior
6,83 $
Intervalo anual
5,96 $ - 9,44 $
Cap. bursátil
63,31 mil M HKD
Volumen medio
55,00
Noticias sobre los mercados
Datos financieros
Estado de resultados
Ingresos
Ingresos netos
| (CNY) | mar 2025info | Cambio interanual |
|---|---|---|
Ingresos | 70,76 mil M | 0,87 % |
Gastos operativos | 4977,41 M | -11,04 % |
Ingresos netos | 1333,07 M | -13,56 % |
Margen de beneficio neto | 1,88 | -14,55 % |
Beneficios por acción | — | — |
EBITDA | 2659,49 M | -5,30 % |
Tipo impositivo efectivo | 23,81 % | — |
Balance general
Activos totales
Responsabilidades totales
| (CNY) | mar 2025info | Cambio interanual |
|---|---|---|
Efectivo y a corto plazo | 45,03 mil M | 21,13 % |
Activos totales | 225,87 mil M | 3,89 % |
Responsabilidades totales | 140,57 mil M | 3,87 % |
Patrimonio total | 85,30 mil M | — |
Acciones en circulación | 3708,36 M | — |
Precio-valor contable | 0,35 | — |
Rentabilidad económica | 2,55 % | — |
Retorno sobre capital | 4,02 % | — |
Flujo de caja
Variación neta del flujo de caja
| (CNY) | mar 2025info | Cambio interanual |
|---|---|---|
Ingresos netos | 1333,07 M | -13,56 % |
Efectivo de operaciones | -2204,32 M | 59,73 % |
Efectivo de inversión | -972,94 M | -152,83 % |
Efectivo de financiación | 3864,21 M | 18,89 % |
Variación neta del flujo de caja | 690,99 M | 284,82 % |
Flujo de caja libre | -6070,50 M | 22,14 % |
Información sobre la empresa
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of year 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
Fundación
18 ene 1994
Sitio web
Empleados
49.402
